The discovery of TRAIL (TNF Related Apoptosis Inducing Ligand), also referred to as Apo-2, is in an era of intense research because TRAIL induces many cancer cells to undergo programmed cell death (apoptosis), while having no effect on normal cells. This important protein deserves extensive review at a formative time in the devlopement of our knowledge concerning its mechanism of action and the ways in which it can be used as a cancer chemotherapeutic agent. Consequently, this voume reviews the current status of research on TRAIL.
* Crystal Structure of RANK Ligand involved in bone metabolism
* Promoter of TRAIL-R2 Gene
* Monoclonal Antibodies against TRAIL
* Modulation of TRAIL signaling complex
* TRAIL in the airways
* FLIP Protein and TRAIL-Induced Apoptosis
* TRAIL and Ceramide
* TRAIL and Viral Infection
* TRAIL and Malignant Glioma
"synopsis" may belong to another edition of this title.
This volume on TRAIL range from structure, biology, and biochemistry to the foundations for the use of TRAIL as a chemotherapeutic agent.About the Author:
Trained in biochemistry at the University of Wisconsin, Madison, Dr. Litwack worked on enzymology and the effects of hormones on enzyme systems. Then he was a Postdoctoral Fellow of the National Foundation for Infantile Paralysis at the Biochemical Institute of the Sorbonne in Paris. Dr. Litwack's first position was as Assistant Professor of Biochemistry at Rutgers University in 1954. Six years later, he joined the University of Pennsylvania as associate professor and four years later went to the Fels Institute for Cancer Research and Molecular Biology, as full professor, eventually becoming Deputy Director of the Institute. In 1991, he accepted the Chair of Pharmacology at Thomas Jefferson University where he is also Deputy Director of the Jefferson Cancer Institute and Associate Director for Basic Science in the Jefferson Cancer Center. Dr. Litwack's work has been in the area of mechanisms of steroid receptor action involving especially the glucocorticoid and mineralocorticoid receptors, immunophi.
"About this title" may belong to another edition of this title.
Book Description Elsevier -, -. Book Condition: NEW. -- (illustrator). Original Books from across the World in Brand New Condition --------- It can be shipped from U.S, Canada, Germany & India/Overseas centre subject to availability.____0631193049_____9780127098678. book. Bookseller Inventory # SIP-STK-40
Book Description Elsevier. Book Condition: New. Original Books from across the World in Brand New Condition --------- It can be shipped from U.S, Canada, Germany & India/Overseas centre subject to availability.,9780127098678. book. Bookseller Inventory # SI-2016-2523
Book Description Book Condition: Brand New. Brand New Original US Edition, Perfect Condition. Printed in English. Excellent Quality, Service and customer satisfaction guaranteed!. Bookseller Inventory # AIND-1918
Book Description Book Condition: New. New. US edition. Perfect condition. Ship by express service to USA, Canada, Australia, France, Italy, UK, Germany and Netherland. Customer satisfaction our priority. Bookseller Inventory # ABE-190516-6381
Book Description Book Condition: Brand New. New. US edition. Customer Satisfaction guaranteed!!. Bookseller Inventory # SHAK6381
Book Description Academic Press, 2004. Hardcover. Book Condition: New. 1. Bookseller Inventory # DADAX0127098674
Book Description Elsevier. Book Condition: New. pp. 448. Bookseller Inventory # 8360395
Book Description Academic Press, 2004. Hardcover. Book Condition: New. book. Bookseller Inventory # 0127098674
Book Description Book Condition: Brand New. Ships from multiple locations. FedEx or DHL 4-6 business days delivery to your doorstep. Bookseller Inventory # 20JULY16APP-2370
Book Description Book Condition: Brand New. Book Condition: Brand New. Bookseller Inventory # 97801270986781.0